ID   VP267
AC   CVCL_2755
SY   VP 267
DR   BioSample; SAMN03472912
DR   cancercelllines; CVCL_2755
DR   Cell_Model_Passport; SIDM01825
DR   ECACC; 05092805
DR   EGA; EGAS00001002554
DR   GEO; GSM115114
DR   GEO; GSM217609
DR   Progenetix; CVCL_2755
DR   Wikidata; Q54993322
RX   PubMed=8877005;
RX   PubMed=11044355;
RX   PubMed=15677628;
RX   PubMed=25877200;
RX   PubMed=29045385;
WW   https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/VP267.html
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=29045385).
CC   Omics: Deep exome analysis.
ST   Source(s): ECACC=05092805; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 18
ST   Penta D: 10
ST   Penta E: 13,17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2754 ! VP229
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
RX   PubMed=8877005; DOI=10.1007/BF01806153;
RA   McCallum H.M., Lowther G.W.;
RT   "Long-term culture of primary breast cancer in defined medium.";
RL   Breast Cancer Res. Treat. 39:247-259(1996).
//
RX   PubMed=11044355; DOI=10.1054/bjoc.2000.1458;
RA   Davidson J.M., Gorringe K.L., Chin S.-F., Orsetti B., Besret C.,
RA   Courtay-Cahen C., Roberts I., Theillet C., Caldas C., Edwards P.A.W.;
RT   "Molecular cytogenetic analysis of breast cancer cell lines.";
RL   Br. J. Cancer 83:1309-1317(2000).
//
RX   PubMed=15677628; DOI=10.1093/carcin/bgi032;
RA   Gorringe K.L., Chin S.-F., Pharoah P.D.P., Staines J.M., Oliveira C.,
RA   Edwards P.A.W., Caldas C.;
RT   "Evidence that both genetic instability and selection contribute to
RT   the accumulation of chromosome alterations in cancer.";
RL   Carcinogenesis 26:923-930(2005).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=29045385; DOI=10.1038/nature24006;
RA   Kategaya L., Di Lello P., Rouge L., Pastor R., Clark K.R.,
RA   Drummond J., Kleinheinz T., Lin E., Upton J.-P., Prakash S.,
RA   Heideker J., McCleland M.L., Ritorto M.S., Alessi D.R., Trost M.,
RA   Bainbridge T.W., Kwok M.C.M., Ma T.P., Stiffler Z., Brasher B.,
RA   Tang Y.-Y., Jaishankar P., Hearn B.R., Renslo A.R., Arkin M.R.,
RA   Cohen F., Yu K.-B., Peale F.V., Gnad F., Chang M.T., Klijn C.,
RA   Blackwood E., Martin S.E., Forrest W.F., Ernst J.A., Ndubaku C.,
RA   Wang X.-J., Beresini M.H., Tsui V., Schwerdtfeger C., Blake R.A.,
RA   Murray J., Maurer T., Wertz I.E.;
RT   "USP7 small-molecule inhibitors interfere with ubiquitin binding.";
RL   Nature 550:534-538(2017).
//